# Effect of Camel Milk on Chronic Hepatitis C

> **NCT02216045** · PHASE2 · COMPLETED · sponsor: **Mashhad University of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peginterferon, Ribavirin, camel milk
- **DRUG:** Peginterferon, Ribavirin

## Key facts

- **NCT ID:** NCT02216045
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216045, "Effect of Camel Milk on Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02216045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*